Legal Proceedings
−Removed: During 2020, VectorY B.V., a Netherlands-based gene therapy company founded in August 2020 by Forbion International Management B.V., hired Pavlina Konstantinova and several other former uniQure employees, which we believed was in violation of the employment agreements of those employees and involved the misappropriation of our proprietary resources.
On or about February 22, 2021, Dr.
11 unchanged sentences
On April 16, 2021, we settled all matters related to the dispute described above (the “Settlement”).
−Removed: In connection with the Settlement, we will receive preference shares in VectorY representing 5% of the fully diluted share capital in VectorY.
−Removed: In addition, we and certain Forbion entities entered into the Cooperation Agreement described below.
−Removed: Under the terms of the Cooperation Agreement, the Forbion Entities have agreed, among other things, for a period of two years from April 16, 2021:
+Added: In connection with the Settlement, we received, among other things, preference shares in VectorY representing 5% of the fully diluted share capital in VectorY.
+Added: In addition, we and certain related Forbion entities entered into a Cooperation Agreement.
+Added: Under the terms of the Cooperation Agreement, we and the Forbion entities agreed to certain non-disparagement provisions, and the Forbion entities agreed, among other things, for a period of two years from April 16, 2021:
To vote all of their ordinary shares in uniQure N.V.
(1) in favor of the re-election of any persons serving on the Board of Directors of the Company (the “Board”) as of the date of the Cooperation Agreement and nominated by the Board for re-election;
−Removed: (2) against any nominees to serve on the Board who have not been recommended by the Board, and (3) with respect to all other matters, other than a Voting Exempt Matter, in accordance with the Board’s recommendations as identified in our notice of general meeting or any supplement thereto.
−Removed: For purposes of the Cooperation Agreement, a “Voting Exempt Matter” means, with respect to the Company, any shareholder vote taken to approve or ratify any merger, acquisition, recapitalization, restructuring, financing, disposition, distribution, spin-off, sale or transfer of all or substantially all of our or any of its affiliates’ assets in one or a series of transactions, joint venture or other business combination of uniQure N.V.
−Removed: or any of its affiliates with a third party or certain other similar transactions.
+Added: (2) against any nominees to serve on the Board who have not been recommended by the Board, and (3) with respect to all other matters, other than certain defined exempt matters, in accordance with the Board’s recommendations as identified in our notice of general meeting or any supplement thereto.
Not to make any announcement or proposal with respect to, or offer, seek, propose, or indicate an interest in (A) any form of business combination or acquisition or other transaction relating to assets or securities of the uniQure N.V.
3 unchanged sentences
Not to take certain other specified actions aimed at changing or influencing the Board, management, or control of the uniQure N.V.
−Removed: We and the Forbion Entities have also agreed to certain non-disparagement provisions.
−Removed: Based on a Schedule 13G/A filed by For UniQure B.V.
−Removed: and Forbion I Management B.V.
−Removed: on February 16, 2021, ForUniQure held 4,386,742 ordinary shares of uniQure N.V.
−Removed: or approximately 9.5% of our issued outstanding ordinary shares.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.